Sit Investment Associates Has Cut Its Ryder System (R) Position; Depomed Has 0.93 Sentiment

Depomed, Inc. (NASDAQ:DEPO) Logo

Sit Investment Associates Inc decreased Ryder System Inc (R) stake by 78.19% reported in 2017Q4 SEC filing. Sit Investment Associates Inc sold 16,675 shares as Ryder System Inc (R)’s stock declined 17.06%. The Sit Investment Associates Inc holds 4,650 shares with $391,000 value, down from 21,325 last quarter. Ryder System Inc now has $3.94 billion valuation. The stock increased 2.87% or $2.07 during the last trading session, reaching $74.16. About 609,939 shares traded or 2.12% up from the average. Ryder System, Inc. (NYSE:R) has declined 3.54% since April 17, 2017 and is downtrending. It has underperformed by 15.09% the S&P500.

Depomed Inc (DEPO) investors sentiment decreased to 0.93 in Q4 2017. It’s down -0.28, from 1.21 in 2017Q3. The ratio fall, as 70 institutional investors increased and opened new equity positions, while 75 sold and decreased stakes in Depomed Inc. The institutional investors in our database now hold: 55.87 million shares, down from 56.42 million shares in 2017Q3. Also, the number of institutional investors holding Depomed Inc in top ten equity positions decreased from 2 to 1 for a decrease of 1. Sold All: 28 Reduced: 47 Increased: 46 New Position: 24.

Analysts await Ryder System, Inc. (NYSE:R) to report earnings on April, 24 before the open. They expect $0.88 earnings per share, up 7.32% or $0.06 from last year’s $0.82 per share. R’s profit will be $46.75M for 21.07 P/E if the $0.88 EPS becomes a reality. After $1.37 actual earnings per share reported by Ryder System, Inc. for the previous quarter, Wall Street now forecasts -35.77% negative EPS growth.

Among 13 analysts covering Ryder System Inc. (NYSE:R), 7 have Buy rating, 1 Sell and 5 Hold. Therefore 54% are positive. Ryder System Inc. has $115 highest and $54 lowest target. $83.33’s average target is 12.37% above currents $74.16 stock price. Ryder System Inc. had 35 analyst reports since August 28, 2015 according to SRatingsIntel. As per Wednesday, October 14, the company rating was maintained by S&P Research. JP Morgan maintained the shares of R in report on Thursday, October 12 with “Neutral” rating. The rating was maintained by Robert W. Baird with “Buy” on Tuesday, April 10. Seaport Global maintained the stock with “Neutral” rating in Monday, April 24 report. As per Friday, April 21, the company rating was initiated by Seaport Global. On Wednesday, February 3 the stock rating was maintained by RBC Capital Markets with “Sector Perform”. The stock has “Top Pick” rating by RBC Capital Markets on Friday, October 23. Buckingham Research maintained it with “Buy” rating and $90 target in Tuesday, February 20 report. The firm has “Hold” rating given on Tuesday, April 10 by Goldman Sachs. The firm has “Hold” rating by Stifel Nicolaus given on Monday, September 4.

Sit Investment Associates Inc increased Walt Disney Co/The (NYSE:DIS) stake by 47,700 shares to 192,390 valued at $20.68 million in 2017Q4. It also upped Delaware Enh Gbl Div & Inc Fd (NYSE:DEX) stake by 103,319 shares and now owns 994,608 shares. Wells Fargo Inc Opport Fd Ead (EAD) was raised too.

Investors sentiment increased to 1.19 in Q4 2017. Its up 0.17, from 1.02 in 2017Q3. It improved, as 31 investors sold R shares while 82 reduced holdings. 50 funds opened positions while 85 raised stakes. 47.61 million shares or 2.43% more from 46.48 million shares in 2017Q3 were reported. Moreover, Blackrock has 0.02% invested in Ryder System, Inc. (NYSE:R). Bronson Point Limited Com has invested 1.63% in Ryder System, Inc. (NYSE:R). 91,655 are owned by California State Teachers Retirement. State Teachers Retirement System reported 82,123 shares. Petrus Lta holds 0.07% of its portfolio in Ryder System, Inc. (NYSE:R) for 3,467 shares. Ajo Lp has invested 0.91% in Ryder System, Inc. (NYSE:R). Morgan Stanley reported 327,630 shares or 0.01% of all its holdings. Adirondack accumulated 300 shares or 0.02% of the stock. Dekabank Deutsche Girozentrale accumulated 5,200 shares. Cna Financial holds 0.44% or 21,899 shares in its portfolio. 2,964 are owned by Creative Planning. Nj State Employees Deferred Compensation Plan accumulated 0.06% or 4,000 shares. Architects Inc stated it has 0% of its portfolio in Ryder System, Inc. (NYSE:R). Old Mutual Customised Solutions (Proprietary) Limited reported 2,200 shares. Thrivent Fincl For Lutherans holds 11,483 shares.

Armistice Capital Llc holds 2.94% of its portfolio in Depomed, Inc. for 3.66 million shares. Deltec Asset Management Llc owns 826,907 shares or 1.36% of their US portfolio. Moreover, Starboard Value Lp has 0.92% invested in the company for 4.70 million shares. The Massachusetts-based Bogle Investment Management L P De has invested 0.6% in the stock. Perkins Capital Management Inc, a Minnesota-based fund reported 60,650 shares.

Depomed, Inc., a specialty pharmaceutical company, engages in the development, sale, and licensing of products for pain and other central nervous system conditions in the United States. The company has market cap of $438.26 million. It offers Gralise , an once-daily product for the management of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults; and Lazanda (fentanyl) nasal spray, an intranasal fentanyl drug used to manage breakthrough pain in adults. It currently has negative earnings. The firm also provides NUCYNTA ER (tapentadol extended release tablets), a product for the management of pain severe enough to long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults; and NUCYNTA (tapentadol), a product for the management of moderate to severe acute pain in adults.

The stock increased 2.22% or $0.15 during the last trading session, reaching $6.9. About 814,192 shares traded. Depomed, Inc. (DEPO) has declined 57.25% since April 17, 2017 and is downtrending. It has underperformed by 68.80% the S&P500.

Since January 1, 0001, it had 1 buying transaction, and 1 sale for $312,485 activity.

Analysts await Depomed, Inc. (NASDAQ:DEPO) to report earnings on May, 8. They expect $-0.54 earnings per share, down 25.58% or $0.11 from last year’s $-0.43 per share. After $-0.38 actual earnings per share reported by Depomed, Inc. for the previous quarter, Wall Street now forecasts 42.11% negative EPS growth.

Ryder System, Inc. (NYSE:R) Institutional Positions Chart